Learn more

RAPAPORT ELIEZER

Overview
  • Total Patents
    15
About

RAPAPORT ELIEZER has a total of 15 patent applications. Its first patent ever was published in 1982. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SPEROVIE BIOSCIENCES INC, ADJUVANCE TECH INC and JAVELIN PHARMACEUTICALS INC.

Patent filings per year

Chart showing RAPAPORT ELIEZERs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Rapaport Eliezer 15

Latest patents

Publication Filing date Title
US2012128582A1 Methods and compositions of [32P]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases
US2007203091A1 Methods and therapeutic compositions for improving liver, blood flow and skeletal muscle functions in advanced diseases and aging
WO03061568A2 Methods and therapeutic compositions in the treatment of advanced cancer
EP1221945A1 Methods, pharmaceutical and therapeutic compositions for administering adenosine
US7671038B1 Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides
US5227371A Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations
US5049372A Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels
US4880918A Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate